Why Cettire, De Grey Mining, Life360, and Neuren shares are falling today

These ASX shares are ending the week in the red. But why?

| More on:
A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has returned to form on Friday. In afternoon trade, the benchmark index is up 0.5% to 7,759.5 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:

Cettire Ltd (ASX: CTT)

The Cettire share price is down 2% to $3.12. This is despite there being no news out the online luxury retailer. However, this decline could have been driven by concerns over consumer spending following a series of subdued updates from retailers this week. The team at Bell Potter is likely to see this as a buying opportunity. Earlier this week, the broker retained its buy rating and $4.00 price target on the company's shares.

De Grey Mining Limited (ASX: DEG)

The De Grey Mining share price is down 2% to $1.24. Investors have been selling this gold developer's shares following the completion of an institutional entitlement offer and placement. De Grey Mining has raised approximately $514.3 million at a discount of $1.10 per new share. Proceeds from the equity raising, together with existing cash, are expected to fully fund the equity component of the project financing for the Hemi Gold Project in Western Australia. Managing Director, Glenn Jardine, believes the support from existing and new shareholders "reflects the high quality of the Hemi Gold Project at a global level."

Life360 Inc (ASX: 360)

The Life360 share price is down 3% to $15.00. This follows the release of the location technology company's first quarter update. Although Life360 delivered very strong growth across the board, the market appears to have been expecting management to lift its guidance for the full year. However, this has only been reiterated despite its impressive start to the financial year. It continues to expect to report consolidated revenue of US$365 million to US$375 million and adjusted EBITDA of US$30 million to US$35 million. The Life360 share price was down as much as 9% at one stage on Friday before rebounding strongly off its lows.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is down almost 2% to $18.98. Investors have been selling this pharmaceuticals company's shares since the release of its quarterly sales update on Thursday. That update revealed that its partner, Acadia Pharmaceuticals (NASDAQ: ACAD) achieved net sales of Daybue in the United States of US$75.9 million. This was a touch short of its guidance of US$76 million to US$82 million. Nevertheless, Acadia reiterated its FY 2024 guidance for net sales of between US$370 million and US$420 million.

Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has recommended Cettire. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Share Fallers

ASX 200 insider buys up another $2,000,000 in company stock following Wednesday's 15% crash

This director took Buffett's advice to heart this week.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why AIC Mines, Fletcher Building, Nufarm, and Wesfarmers shares are dropping

These shares are having a tough finish to the week. But why?

Read more »

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Share Fallers

Why BHP, Nufarm, Peninsula Energy, and Regis Resource shares are sinking today

These ASX shares are having a tough session on Thursday. But why?

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Eagers Automotive, Inghams, Patriot Battery Metals, and Wildcat shares are sinking

These shares are having a tough time on hump day. But why?

Read more »

A man holds his hands to the sides of his face and pulls it down in despair as he sits at the wheel of a car that is not moving, as though in a traffic jam.
Share Fallers

Why this $3.2 billion ASX 200 stock just crashed 19%

The ASX 200 stock is under heavy selling pressure on Wednesday. But why?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Infratil, James Hardie, Sonic Healthcare, and Star Entertainment shares are sinking today

These shares are having a tough session on Tuesday. But why?

Read more »

Male doctor in a lab coat working at laptop looking serious.
Share Fallers

Why this ASX 200 healthcare stock is tumbling 6% today

Inflation pressures are claiming another victim as this healthcare giant lowers its FY24 expectations.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Core Lithium, Duratec, Galan Lithium, and Michael Hill shares are sinking today

These shares are starting the week in the red. But why?

Read more »